|
RAD51AP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.360300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.205000E-03 |
| Normal-vs-Stage2 |
8.548800E-01 |
| Normal-vs-Stage3 |
2.827700E-02 |
| Normal-vs-Stage4 |
1.104370E-01 |
| Stage1-vs-Stage2 |
1.161860E-02 |
| Stage1-vs-Stage3 |
5.909800E-01 |
| Stage1-vs-Stage4 |
5.042000E-01 |
| Stage2-vs-Stage3 |
5.524300E-02 |
| Stage2-vs-Stage4 |
1.634640E-01 |
| Stage3-vs-Stage4 |
8.166200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.010160E-02 |
| Normal-vs-AfricanAmerican |
5.149900E-02 |
| Normal-vs-Asian |
1.918500E-02 |
| Caucasian-vs-AfricanAmerican |
4.287200E-01 |
| Caucasian-vs-Asian |
7.506400E-01 |
| AfricanAmerican-vs-Asian |
5.711800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.040300E-02 |
| Normal-vs-Female |
1.648080E-02 |
| Male-vs-Female |
7.702400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.417100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.548600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.193990E-01 |
| Normal-vs-Age(81-100Yrs) |
1.648590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.863780E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.098400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.874600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.933600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.475440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.311400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.175800E-01 |
| Classical-VS-Follicular |
1.444990E-03 |
| Classical-VS-Other |
7.792400E-01 |
| Classical-VS-Normal |
2.962700E-03 |
| Tall-VS-Follicular |
2.077200E-03 |
| Tall-VS-Other |
3.730600E-01 |
| Tall-VS-Normal |
9.171100E-04 |
| Follicular-VS-Other |
4.341000E-01 |
| Follicular-VS-Normal |
7.094800E-01 |
| Other-VS-Normal |
3.118800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.183900E-02 |
| Normal-vs-N1 |
2.833600E-02 |
| N0-vs-N1 |
5.433800E-01 |
|
|
